HELIUS MEDICAL TECHNOLOGIES, INC. financial data

Symbol
HSDT on Nasdaq, HSDTW on OTC
Location
Newtown, PA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 18 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.54K % +300%
Quick Ratio 48.5 % +39.5%
Debt-to-equity -441 % -576%
Return On Equity 1.03K %
Return On Assets -302 % -137%
Operating Margin -4.88K % -88.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 41.3M shares
Common Stock, Shares, Outstanding 40.3M shares +1005%
Entity Public Float 3.09M USD -41.2%
Common Stock, Value, Issued 40K USD +900%
Weighted Average Number of Shares Outstanding, Basic 10.7M shares
Weighted Average Number of Shares Outstanding, Diluted 10.7M shares

Income Statement

Label TTM Value / Value Unit Change %
Revenues 941K USD +87.5%
Revenue from Contract with Customer, Excluding Assessed Tax 252K USD -54.2%
Research and Development Expense 3.55M USD +4.85%
Operating Income (Loss) -45.9M USD -253%
Nonoperating Income (Expense) -324M USD -7931%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -370M USD -4081%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -370M USD -4081%
Earnings Per Share, Basic 1.12K USD/shares +95.6%
Earnings Per Share, Diluted 1.12K USD/shares +95.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 124M USD +3477%
Accounts Receivable, after Allowance for Credit Loss, Current 12K USD -90.1%
Inventory, Net 1.13M USD +45.7%
Assets, Current 126M USD +2225%
Property, Plant and Equipment, Net 90K USD -45.5%
Operating Lease, Right-of-Use Asset 11K USD -78.8%
Intangible Assets, Net (Excluding Goodwill) 2K USD -93.5%
Other Assets, Noncurrent 82K USD
Assets 476M USD +8421%
Accounts Payable, Current 2.49M USD +234%
Liabilities, Current 3.14M USD +110%
Other Liabilities, Noncurrent 79K USD
Liabilities 628M USD +35080%
Accumulated Other Comprehensive Income (Loss), Net of Tax -60K USD +85.9%
Retained Earnings (Accumulated Deficit) -538M USD -221%
Stockholders' Equity Attributable to Parent -152M USD -4111%
Liabilities and Equity 476M USD +8421%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.54M USD -17.8%
Net Cash Provided by (Used in) Financing Activities 3.56M USD +143%
Common Stock, Shares Authorized 800M shares +433%
Common Stock, Shares, Issued 40.3M shares +1005%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 21K USD
Deferred Tax Assets, Valuation Allowance 41.1M USD +9.33%
Deferred Tax Assets, Gross 41.1M USD +9.24%
Operating Lease, Liability 12K USD -78.9%
Depreciation 8K USD -11.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -370M USD -4092%
Lessee, Operating Lease, Liability, to be Paid 36K USD +2.86%
Property, Plant and Equipment, Gross 502K USD -6.52%
Operating Lease, Liability, Current 12K USD -73.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 12K USD -47.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -50%
Deferred Tax Assets, Operating Loss Carryforwards 32.6M USD +6.5%
Amortization of Intangible Assets 24K USD -79.5%
Share-based Payment Arrangement, Expense 1.93M USD -22.6%